Citation Impact
Citing Papers
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
2000 Standout
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
2008
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
2005 StandoutNobel
Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
2008
The Human Tim/Tipin Complex Coordinates an Intra-S Checkpoint Response to UV That Slows Replication Fork Displacement
2007 StandoutNobel
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
2007
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
1997 StandoutScience
Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer
2004
MCM Proteins Are Negative Regulators of Hypoxia-Inducible Factor 1
2011 StandoutNobel
Biology of basal cell carcinoma (Part I)
1991
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel.
2002
Toxin-induced models of Parkinson’s disease
2005
Nasopharyngeal carcinoma
2005 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
2000
Positive Psychological Well-Being and Mortality: A Quantitative Review of Prospective Observational Studies
2008
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Targeting hypoxia in cancer therapy
2011 Standout
A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma
2013
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma
2003
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
The Chk1-mediated S-phase Checkpoint Targets Initiation Factor Cdc45 via a Cdc25A/Cdk2-independent Mechanism
2006
Cell Proliferation in Carcinogenesis
1990 Science
Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma
2003
Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
2010
Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake
2004
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2005 StandoutNature
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Head and neck cancer
2008 Standout
Nasopharyngeal carcinoma
2019 Standout
Primary CNS Lymphoma: Treatment with Combined Chemotherapy and Radiotherapy
1999
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Lessons from Hereditary Colorectal Cancer
1996 Standout
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation
2005
A Chemical and Genetic Approach Together Define the Biological Consequences of 3-Methyladenine Lesions in the Mammalian Genome
1998
Role of Radiation Therapy in Cutaneous Melanoma
2012
Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study
2008
Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas
2003
Multiple ATR-Chk1 Pathway Proteins Preferentially Associate with Checkpoint-Inducing DNA Substrates
2011 StandoutNobel
Nasopharyngeal carcinoma
2015 Standout
Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancer
2004
Malignant Gliomas in Adults
2008 Standout
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma
2010
How to calculate the dose of chemotherapy
2002
Sister-chromatid exchange: second report of the Gene-Tox program
1993
Development and External Validation of Prognostic Model for 2-Year Survival of Non–Small-Cell Lung Cancer Patients Treated With Chemoradiotherapy
2008
Molecular themes in oncogenesis
1991 StandoutNobel
Dormant origins licensed by excess Mcm2–7 are required for human cells to survive replicative stress
2007
The battle against nasopharyngeal cancer
2012
Subjective wellbeing, health, and ageing
2014 StandoutNobel
Cdc7-Dbf4 and the Human S Checkpoint Response to UVC
2007 StandoutNobel
Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site
2016
Primary brain tumours in adults
2012 Standout
Regulation of Cellular and SV40 Virus Origins of Replication by Chk1-dependent Intrinsic and UVC Radiation-induced Checkpoints
2003
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
2008
Mismatch Repair Deficiency in Phenotypically Normal Human Cells
1995 StandoutScienceNobel
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphoma
2001
Visualization of Altered Replication Dynamics after DNA Damage in Human Cells
2004
Cervical cancer
2019 Standout
Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
2000
Biology of cutaneous squamous cell carcinoma
1992
Angiogenesis as a therapeutic target
2005 StandoutNature
The Saccharomyces cerevisiae RAD9, RAD17, RAD24 and MEC3 Genes Are Required for Tolerating Irreparable, Ultraviolet-Induced DNA Damage
1998 StandoutNobel
Increased Avian Diversity Is Associated with Lower Incidence of Human West Nile Infection: Observation of the Dilution Effect
2008
Brain Tumors
2001 Standout
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Tumour stem cells and drug resistance
2005 Standout
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
2010
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials
2005
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
2008
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma
2001
Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
2003
Extending Survival with Chemotherapy in Metastatic Breast Cancer
2005
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.
2002
Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
2006
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
1992 Standout
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma
2014
Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma
2000
Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA
2004
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Cisplatin Sensitizes Cancer Cells to Ionizing Radiation via Inhibition of Nonhomologous End Joining
2005
Excess Mcm2–7 license dormant origins of replication that can be used under conditions of replicative stress
2006
Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy
2004
Evaluation of Early and Late Toxicities in Chemoradiation Trials
2007
Dose translation from animal to human studies revisited
2007 Standout
Works of Jennifer Smith being referenced
Treatment of nonmelanoma skin cancer at a large australian center
1990
Primary central nervous system lymphoma: age and performance status are more important than treatment modality
1998
The cytogenetic and hepatotoxic effects of dioxin on mouse liver cells
1988
Nodal radiation therapy for metastatic melanoma
1999
Radiation with concurrent late chemotherapy intensification (‘chemoboost’) for locally advanced head and neck cancer
2000
Failure of T stage to predict survival in patients with non-small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapy
2002
Optimism and survival in lung carcinoma patients
2004
A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: An interim toxicity analysis of the first 100 patients
1995
Phase II Trial of Continuous Infusion Carboplatin, 5-Fluorouracil, and Radiotherapy for Localized Cancer of the Esophagus
2002
The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: A randomised double-blind placebo controlled trial
1993
Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer
2003
Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer
1999
Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma—a critique
1999
PATTERNS OF WEST NILE VIRUS INFECTION IN OHIO BLUE JAYS: IMPLICATIONS FOR INITIATION OF THE ANNUAL CYCLE
2004
Paraquat Poisoning by Skin Absorption: A Review
1988
Hepatotoxic doses of dioxin do not damage mouse bone marrow chromosomes
1985
Excellent Disease Control and Survival in Patients With Advanced Nasopharyngeal Cancer Treated With Chemoradiation
2002
The concept of a planned neck dissection is obsolete.
2002